Royalty Pharma: Attractive Business Model; Vertex CF Royalties Uncertain

Dollar roll with sign royalty and keyboard.

designer491/iStock via Getty Images


Royalty Pharma (Nasdaq: RPRX) is a profitable, dividend paying company with a business model that involves purchasing royalty streams. It has provided funding for unprofitable biotech companies, funded R&D projects for large pharma companies and purchased commercial products such as royalties.

Also Read :  Michelle Wu scrubs graffiti, touts open city jobs in Boston
Also Read :  Exclusive: Google faces EU antitrust charges over its adtech business - sources
Also Read :  Freshers look for other jobs, as IT companies delay joining


Leave a Reply

Your email address will not be published.